157 related articles for article (PubMed ID: 7636236)
21. Phosphorylation regulates the delivery of MHC class II invariant chain complexes to antigen processing compartments.
Anderson HA; Roche PA
J Immunol; 1998 May; 160(10):4850-8. PubMed ID: 9590232
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
Rock KL; Clark K
J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
[TBL] [Abstract][Full Text] [Related]
23. Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF.
Raviprakash K; Marques E; Ewing D; Lu Y; Phillips I; Porter KR; Kochel TJ; August TJ; Hayes CG; Murphy GS
Virology; 2001 Nov; 290(1):74-82. PubMed ID: 11883007
[TBL] [Abstract][Full Text] [Related]
24. Enhanced induction of telomerase-specific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product.
Su Z; Vieweg J; Weizer AZ; Dahm P; Yancey D; Turaga V; Higgins J; Boczkowski D; Gilboa E; Dannull J
Cancer Res; 2002 Sep; 62(17):5041-8. PubMed ID: 12208759
[TBL] [Abstract][Full Text] [Related]
25. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
Barbouche R; Decroly E; Kieny MP; Fenouillet E
Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
[TBL] [Abstract][Full Text] [Related]
26. Class I-restricted presentation of an HIV-1 gp41 epitope containing an N-linked glycosylation site. Implications for the mechanism of processing of viral envelope proteins.
Ferris RL; Buck C; Hammond SA; Woods AS; Cotter RJ; Takiguchi M; Igarashi Y; Ichikawa Y; Siliciano RF
J Immunol; 1996 Jan; 156(2):834-40. PubMed ID: 8543840
[TBL] [Abstract][Full Text] [Related]
27. Envelope glycoproteins of HIV-1 interfere with T-cell-dependent B cell differentiation: role of CD4-MHC class II interaction in the effector phase of T cell help.
Chirmule N; Wang XP; Hu R; Oyaizu N; Roifman C; Pahwa R; Kalyanaraman VS; Pahwa S
Cell Immunol; 1994 Apr; 155(1):169-82. PubMed ID: 8168144
[TBL] [Abstract][Full Text] [Related]
28. Fusion of human B cell lines with HIV-1 envelope-expressing T cells is enhanced by antigen-specific Ig receptors. Possible mechanism for elimination of gp120-specific B cells in vivo.
Golding H; Dimitrov DS; Blackburn R; Manischewitz J; Blumenthal R; Golding B
J Immunol; 1993 Mar; 150(6):2506-16. PubMed ID: 7680694
[TBL] [Abstract][Full Text] [Related]
29. The human immunodeficiency virus type 1 Vpu protein tethered to the CD4 extracellular domain is localized to the plasma membrane and is biologically active in the secretory pathway of mammalian cells: implications for the mechanisms of Vpu function.
Raja NU; Jabbar MA
Virology; 1996 Jun; 220(1):141-51. PubMed ID: 8659106
[TBL] [Abstract][Full Text] [Related]
30. Human dendritic cell lysosome-associated membrane protein expressed in lung type II pneumocytes.
Akasaki K; Nakamura N; Tsukui N; Yokota S; Murata S; Katoh R; Michihara A; Tsuji H; Marques ET; August JT
Arch Biochem Biophys; 2004 May; 425(2):147-57. PubMed ID: 15111122
[TBL] [Abstract][Full Text] [Related]
31. Immunogenic peptides bind to class II MHC molecules in an early lysosomal compartment.
Harding CV; Geuze HJ
J Immunol; 1993 Oct; 151(8):3988-98. PubMed ID: 8409381
[TBL] [Abstract][Full Text] [Related]
32. Targeting a polyepitope protein incorporating multiple class II-restricted viral epitopes to the secretory/endocytic pathway facilitates immune recognition by CD4+ cytotoxic T lymphocytes: a novel approach to vaccine design.
Thomson SA; Burrows SR; Misko IS; Moss DJ; Coupar BE; Khanna R
J Virol; 1998 Mar; 72(3):2246-52. PubMed ID: 9499082
[TBL] [Abstract][Full Text] [Related]
33. Liposome-encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation.
Harding CV; Collins DS; Kanagawa O; Unanue ER
J Immunol; 1991 Nov; 147(9):2860-3. PubMed ID: 1918996
[TBL] [Abstract][Full Text] [Related]
34. Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens.
Zhou D; Li P; Lin Y; Lott JM; Hislop AD; Canaday DH; Brutkiewicz RR; Blum JS
Immunity; 2005 May; 22(5):571-81. PubMed ID: 15894275
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 p55Gag encoded in the lysosome-associated membrane protein-1 as a DNA plasmid vaccine chimera is highly expressed, traffics to the major histocompatibility class II compartment, and elicits enhanced immune responses.
Marques ET; Chikhlikar P; de Arruda LB; Leao IC; Lu Y; Wong J; Chen JS; Byrne B; August JT
J Biol Chem; 2003 Sep; 278(39):37926-36. PubMed ID: 12824194
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 trafficking to the dendritic cell-T-cell infectious synapse uses a pathway of tetraspanin sorting to the immunological synapse.
Garcia E; Pion M; Pelchen-Matthews A; Collinson L; Arrighi JF; Blot G; Leuba F; Escola JM; Demaurex N; Marsh M; Piguet V
Traffic; 2005 Jun; 6(6):488-501. PubMed ID: 15882445
[TBL] [Abstract][Full Text] [Related]
37. The enhanced immune response to the HIV gp160/LAMP chimeric gene product targeted to the lysosome membrane protein trafficking pathway.
Ruff AL; Guarnieri FG; Staveley-O'Carroll K; Siliciano RF; August JT
J Biol Chem; 1997 Mar; 272(13):8671-8. PubMed ID: 9079699
[TBL] [Abstract][Full Text] [Related]
38. Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens.
Wu TC; Guarnieri FG; Staveley-O'Carroll KF; Viscidi RP; Levitsky HI; Hedrick L; Cho KR; August JT; Pardoll DM
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11671-5. PubMed ID: 8524826
[TBL] [Abstract][Full Text] [Related]
39. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen.
Lin KY; Guarnieri FG; Staveley-O'Carroll KF; Levitsky HI; August JT; Pardoll DM; Wu TC
Cancer Res; 1996 Jan; 56(1):21-6. PubMed ID: 8548765
[TBL] [Abstract][Full Text] [Related]
40. LAMP-2-deficient human B cells exhibit altered MHC class II presentation of exogenous antigens.
Crotzer VL; Glosson N; Zhou D; Nishino I; Blum JS
Immunology; 2010 Nov; 131(3):318-30. PubMed ID: 20518820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
